Pamela Ann Connealy, CFO at Immunovant, holds 2.31M shares in Pyxis Oncology (Ticker: PYXS), holds 21.29K shares in Orchestra BioMed Holdings (Ticker: OBIO), holds 46.20K shares in Immunovant (Ticker: IMVT). Most recently, Pamela Ann Connealy Bought ― shares of Pyxis Oncology on Nov 27, 2024 for an estimated value of 174.36K.
What is the percentage of profitable transactions made by Pamela Ann Connealy?
The percentage of profitable transactions made by Pamela Ann Connealy is 80%.
What is the average return per transaction made by Pamela Ann Connealy?
The average return per transaction made by Pamela Ann Connealy is 78.80%.
What stocks does Pamela Ann Connealy hold?
Pamela Ann Connealy holds: IMVT, PYXS, OBIO stocks.
What was Pamela Ann Connealy’s latest transaction?
Pamela Ann Connealy latest transaction was an Informative Buy of $174.36K.
What was Pamela Ann Connealy's most profitable transaction?
Pamela Ann Connealy’s most profitable transaction was an Informative Buy of PYXS stock on September 22, 2023. The return on the trade was 130.60%.
What is Pamela Ann Connealy's role in Immunovant?
Pamela Ann Connealy's role in Immunovant is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.